FDA scientists opposed Trump administration’s move to ease peptide access

Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr , was opposed by most Food and Drug…